Loading...
Back
CRDL
CRDL
CARDIOL THERAPEUTICS INC
(CRDL)
2026 6-K
Follow
Summary
Share
Summary
Investor Conference
14 May '26
Financial Report Filed
11 May '26
Publication Announcement
7 May '26
Trial Network Expansion
28 Apr '26
Filing Update
14 Apr '26
Filing Notice
10 Apr '26
Year-End Update
1 Apr '26
Conference Announcement
25 Feb '26
ARCHER Phase II Study
10 Feb '26
Underwriting Agreement
2 Feb '26
Form 6-K Filing
26 Jan '26
Financing Success
23 Jan '26
6-K Filing Report
16 Jan '26
Enrollment Milestone
13 Jan '26
New Trial Data
1 Dec '25
Filing Update
13 Nov '25
Patent Approval Achieved
13 Nov '25
Trial Results Announcement
5 Nov '25
Filing Notice
27 Oct '25
Filing Update
27 Oct '25
Financing Update
21 Oct '25
Funding Acquisition
17 Oct '25
Filing Details
14 Aug '25
Conference Participation
11 Aug '25
ARCHER Trial Results
6 Aug '25
ARCHER Trial Update
22 Jul '25
Annual Meeting Results
29 May '25
Annual Meeting Webcast
27 May '25
Financial Report
14 May '25
Board Appointment
29 Apr '25
Annual General Meeting
28 Apr '25
Clinical Trial Update
16 Apr '25
Year-End Update
1 Apr '25
Report Filing
14 Mar '25
Conference Presentation
3 Mar '25
Research Publication
20 Feb '25
Conference Presentation
4 Feb '25
Clinical Results Presented
18 Nov '24
Filing Report
14 Nov '24
Clinical Trial Update
22 Oct '24
Over-Allotment Closing
11 Oct '24
Public Offering Closed
10 Oct '24
Public Offering Announcement
9 Oct '24
Public Offering Filing
8 Oct '24
Trial Enrollment Success
24 Sep '24
Study Completion Announcement
10 Sep '24
Company Filing Update
12 Aug '24
Filing Submission
16 Jul '24
AGM Voting Results
27 Jun '24
Annual Meeting Webinar
25 Jun '24
Positive Data Announcement
13 Jun '24
Annual Meeting Notice
28 May '24
Filing Update
14 May '24
ARCHER Trial Update
14 May '24
Filing Notification
26 Apr '24
Company Update
2 Apr '24
Material Change Report
26 Feb '24
Study Enrollment Complete
21 Feb '24
Orphan Drug Designation
15 Feb '24
Listing Compliance Confirma...
24 Jan '24
Enrollment Update
9 Jan '24
External Links:
SEC
Cardiol Therapeutics Inc. filed a Form 6-K with the SEC on January 16, 2026, reporting the submission of its news release for January 2026.
AI Assistant
Close
CARDIOL THERAPEUTICS INC
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.